Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Gains 3%; BSE HEALTHCARE Index Up 0.8%
Wed, 21 Aug 10:7

Divis Laboratories Gains 3%; BSE HEALTHCARE Index Up 0.8%Image source: StarLineArts/www.istockphoto.com

Divis Laboratories share price has zoomed 3% and is presently trading at Rs 4,879.9.

Meanwhile, the BSE HEALTHCARE index is at 41,949.9 (up 0.8%).

Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 3.4%) and SUVEN PHARMACEUTICALS (up 2.7%).

Aurobindo Pharma (down 1.2%) and MAX HEALTHCARE INSTITUTE (down 0.5%) are among the top losers today.

Over the last one year, Divis Laboratories has moved up from Rs 3,664.4 to Rs 4,879.9, registering a gain of Rs 1,215.6 (up 33.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 41,949.9, registering a gain of 49.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 128.8%), Glenmark Pharma (up 114.3%) and GSK Pharma (up 111.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,710.8 (down 0.1%).

The top losers among the BSE Sensex today are Ultratech Cement (down 1.8%) and ICICI Bank (down 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,697.8 . Ultratech Cement and ICICI Bank are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 80,710.8, registering a gain of 15,494.7 points (up 23.8%).

Divis Laboratories Financial Update...

Divis Laboratories net profit grew 20.8% YoY to Rs 4,300 million for the quarter ended June 2024, compared to a profit of Rs 3,560 million a year ago. Net sales rose 19.1% to Rs 21,180 million during the period as against Rs 17,780 million in April-June 2023.

For the year ended March 2024, Divis Laboratories reported 12.3% decrease in net profit to Rs 16,000 million compared to net profit of Rs 18,240 million during FY23. Revenue of the company grew 1.0% to Rs 78,450 million during FY24.

The current Price to earnings ratio of Divis Laboratories, based on rolling 12 month earnings, stands at 77.4.


Equitymaster requests your view! Post a comment on "Divis Laboratories Gains 3%; BSE HEALTHCARE Index Up 0.8%". Click here!